ResMed is a global manufacturer of products for the treatment of sleep disorders, particularly obstructive sleep apnea (OSA). ResMed employs more than 4300 employees worldwide, it operates in 100 countries and has manufacturing in Australia, France, Singapore and the United States. In the fiscal year 2013/2014 it achieved revenues of US$ 1.5 billion.[ Corporate Factsheet (PDF)] ResMed considers the OSA market as underpenetrated and joined a partnership with LifeScan, a Johnson & Johnson company in 2009 to increase awareness of OSA amongst type 2 diabetes patients. ResMed also raises awareness of the serious comorbidities linked to untreated …


  Back to overview